BeCare MS Link can replicate the EDSS calculated by your physician. The MS app is a validated neurologic assessment that can help MS patients and the doctors treating them. https://meridian.allenpress.com/ijmsc/article/doi/10.7224/1537-2073.2023-009/495666/Validated-Quantitative-Machine-Learning-Generated
Our Chief Medical Officer, Dr. Charisse Litchman, has just been nominated as one of the Top 50 Women Leaders in Healthcare, a well-deserved recognition of her outstanding contributions to the medical field! 🏥💪 Throughout her career, Dr. Litchman has been a beacon of excellence, compassion, and innovation. Her dedication to advancing patient care and her …
🌟 Celebrating Dr. Charisse Litchman: A Top 50 Women Leader in Healthcare! 🌟 Read More »
We are honored to join the impressive innovators at MATTER, all focused on improving healthcare for all. https://matter.health/posts/july-2023-meet-the-newest-members-of-the-matter-startup-community/?utm_source=linkedin&utm_medium=social&utm_campaign=new-members
BeCare Link nationally launched its first health monitoring product BeCare MS Link at the Pepcom Wellness Now! media showcase in New York City on May 11, 2023. BeCare Link is an AI-driven platform for quantitatively assessing neurologic function on a mobile phone. BeCare MS Link, the first of BeCare Link’s one-of-a-kind apps, is available in …
National Launch of BeCare MS Link Health Monitoring Platform Read More »
Selected by Judges and Audience as Winner of MedCity INVEST Pitch Perfect Competition BeCare Link was recognized as the winner of the recent INVEST Pitch Perfect start-up competition, held by MedCity as part of its INVEST PharmaTech conference on July 27, 2022. Selected by both the judges and the conference attendees as the top choice, BeCare Link’s gamified …
BeCare Link was one of eleven digital health start-ups which graduated from PharmStars™ Spring 2022 accelerator program. Selected in March 2022 through a competitive application process, BeCare Link completed a 10-week program which provides education and mentorship to help start-ups partner more effectively with pharmaceutical companies. Bridging Pharma and Start-ups to Drive Digital Health Adoption The …
BeCare Link Graduates from Digital Health Start-ups’ Accelerator Program Read More »
In 2021, BeCare App was granted FDA approval for marketing to US users without additional regulatory requirements. The BeCare MS Link mobile app is available to the general public, including all activities, questionnaires, and healthcare provider features. The unique app received Class I classification in 2021. However, the proprietary EDSS scoring is currently only available …
BeCare Link Cleared for FDA-Class I Classification Read More »
Congratulations again to the 2019 “Addressing Unmet Needs in MS: An Innovation Challenge” finalists. The ten finalists, including BeCare Link, were recognized as outstanding patient entrepreneurs. These companies are developing innovations in medicine and solutions to address an unmet need in treating multiple sclerosis. Celgene was so inspired by the companies, that we will award …
BeCareLink Recognized for Innovation in Multiple Sclerosis Read More »
BeCare Link was recognized as one of two pitch winners at the 2019 Health 2.0 VentureConnect. BeCare Link’s innovation in providing healthcare data solutions earned the start-up the honor. By leveraging artificial intelligence (AI) and its innovative technology platform, BeCare Link promises to transform the treatment of chronic diseases. Background on Health 2.0 VentureConnect In …
BeCareLink Named Health 2.0 VentureConnect Pitch Winner – February 2019 Read More »
One of the New MS Treatments: Perfect App for Anyone Living with Multiple Sclerosis MyTherapy rated three apps as ideal for people living with MS in June of 2018. The conclusion:Â BeCare Link is a perfect app, and is one of the new MS treatments. The author Dan Brown elaborates below: “If you are living …
BeCareLink voted best app for tracking MS progress – June 2018 Read More »
